SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001438533-24-000014
Filing Date
2024-03-27
Accepted
2024-03-27 16:35:55
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-03-27

Document Format Files

Seq Description Document Type Size
1 ARS travereannualreportars.pdf ARS 1984495
  Complete submission text file 0001438533-24-000014.txt   2734615
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36257 | Film No.: 24791369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)